H. U. Luleyap

ISL2 is an epigenetically silenced tumor suppressor and regulator of metabolism in pancreatic cancer

Mazhar Adli, N. Bardeesy, Cem Kuscu, 2020, bioRxiv.

ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer.

Mazhar Adli, N. Bardeesy, D. Ting, 2022, Developmental cell.

Association between pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections disease and tumor necrosis factor-α gene−308 g/a, −850 c/t polymorphisms in 4-12-year-old children in Adana/Turkey

D. Alptekin, A. Pazarbasi, A. Tahiroglu, 2013, Indian journal of human genetics.

Use of Enzyme-Linked Immunosorbent Assay for Detection of Natural Leishmania Infections in Phlebotomine Sand Flies from Southeastern Turkey

H. Kasap, M. Kasap, D. Alptekin, 2006, Journal of medical entomology.

Evaluation of the effects of androgen receptor gene trinucleotide repeats and prostate-specific antigen gene polymorphisms on prostate cancer.

Y. Bayazıt, D. Alptekin, H. U. Luleyap, 2012, Genetics and molecular research : GMR.